Keywords: Liver, Elastography, Liver, tumor, biomechanics, Vessels
Motivation: Combination therapies using cytotoxic and anti-angiogenic drugs for hepatic metastases from colorectal cancer are currently presenting radiological challenges for monitoring treatment efficacy
Goal(s): Can vascular architecture quantified through its fractality and measured non-invasively via multi-frequency MRE be used to gauge response to novel combination therapies acting on cells and vessels simultaneously
Approach: The study used multifrequency MRE to measure the Hurst index, quantifying vascular fractality in murine models treated with different therapies.
Results: The combination of BEVACIZUMAB and FOLFOX normalized tumor vascular organization, significantly impacting vascular fractality as compared to single drug treatments. Invivo and histological vessel fractality match.
Impact: This approach offers a non-invasive biomarker for evaluating therapies, advancing personalized treatments for liver metastases
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords